22 Nw, LP Lian Bio Transaction History

22 Nw, LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 14, 2023	BUY	$1.49 - $2.46 $3.08 Million - $5.09 Million	2,070,455 Added 1466.09%	2,211,678 $3.3 Million
Q2 2022 Aug 12, 2022	BUY	$2.15 - $6.01 $303,629 - $848,750	141,223 New	141,223 $305,000

1.09M

Ticker LIAN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,354,000
Market Cap $32.5M
Description
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...

Get notified when there are updates to the investment portfolio of 22 Nw, LP, based on Form 13F filings with the SEC.

Stay updated on 22 Nw, LP with notifications on news.